A. Gregory Sorensen, MD

Massachusetts General Hospital

Boston, Massachusetts - 02114

CLINICAL TRIALS 1
CONDITIONS4
INTERVENTIONS5
SINCE2009

PET Scan Using 18F-Fluoromisonidazole and MRI In Assessing Tumor Hypoxia in Patients With Newly Diagnosed Glioblastoma Multiforme

August 2009 - May 2010

Nervous System Neoplasms

Central Nervous System Neoplasms

Glioblastoma

Anoxia

Magnetic Resonance Imaging

Radiation Therapy

Temozolomide

18f-Fluoromisonidazole

Tissue Oxygen Measurement

Learn about TrialX Patient Recruitment services

Massimo Loda, MD

Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute

Suzanne Shusterman

Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute Childrens Hospital Boston, Dana-Farber Cancer Institute. Children's Hospital Boston

Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute Dana-Farber Cancer Institute Dana Farber / Brigham and Women's Cancer Center Dana-Farber Cancer Institute, Center for Neuro-Oncology Dana-Farber Cancer Instiute

Lewis B. Silverman, MD

Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute Dana-Farber Cancer Institute and Children's Hospital Dana Faber Cancer Institute, Children's Hospital, Dept. of Pediatric Oncology Children's Hospital Boston Dana-Farber Cancer Institute

A. Gregory Sorensen, MD

Massachusetts General Hospital

Massimo Loda, MD

Suzanne Shusterman

Patrick Y. Wen, MD

Lewis B. Silverman, MD

Kay Kehoe, Coordinator

Jennifer Brown, MD

Rachel A. Freedman

Edwin P. Alyea, MD

F. Stephen Hodi, MD

Beth A. Overmoyer, MD, FACP